OpenURL Connection Search

Select item for more details and to access through your institution.

N<sup>4</sup>-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses.
Published in:
PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1012574
By:
- Ojha, Durbadal;
- Hill, Collin S.;
- Zhou, Shuntai;
- Evans, Alyssa;
- Leung, Jacqueline M.;
- Schneider, Christine A.;
- Amblard, Franck;
- Woods, Tyson A.;
- Schinazi, Raymond F.;
- Baric, Ralph S.;
- Peterson, Karin E.;
- Swanstrom, Ronald
Publication type:
Article
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Published in:
Science Translational Medicine, 2020, v. 12, n. 541, p. 1, doi. 10.1126/scitranslmed.abb5883
By:
- Sheahan, Timothy P.;
- Sims, Amy C.;
- Zhou, Shuntai;
- Graham, Rachel L.;
- Pruijssers, Andrea J.;
- Agostini, Maria L.;
- Leist, Sarah R.;
- Schäfer, Alexandra;
- Dinnon III, Kenneth H.;
- Stevens, Laura J.;
- Chappell, James D.;
- Lu, Xiaotao;
- Hughes, Tia M.;
- George, Amelia S.;
- Hill, Collin S.;
- Montgomery, Stephanie A.;
- Brown, Ariane J.;
- Bluemling, Gregory R.;
- Natchus, Michael G.;
- Saindane, Manohar
Publication type:
Article
Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.
Published in:
Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 86, doi. 10.1093/infdis/jiae131
By:
- Burdorf, Rachel M;
- Zhou, Shuntai;
- Amon, Claire;
- Long, Nathan;
- Hill, Collin S;
- Adams, Lily;
- Tegha, Gerald;
- Chagomerana, Maganizo B;
- Jumbe, Allan;
- Maliwichi, Madalitso;
- Wallie, Shaphil;
- Li, Yijia;
- Swanstrom, Ronald;
- Hosseinipour, Mina C
Publication type:
Article
Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission.
Published in:
Journal of Infectious Diseases, 2023, v. 228, n. 12, p. 1758, doi. 10.1093/infdis/jiad211
By:
- Zhou, Shuntai;
- Long, Nathan;
- Moeser, Matt;
- Hill, Collin S;
- Samoff, Erika;
- Mobley, Victoria;
- Frost, Simon;
- Bayer, Cara;
- Kelly, Elizabeth;
- Greifinger, Annalea;
- Shone, Scott;
- Glover, William;
- Clark, Michael;
- Eron, Joseph;
- Cohen, Myron;
- Swanstrom, Ronald;
- Dennis, Ann M
Publication type:
Article
Reply to Troth et al.
Published in:
2021
By:
- Zhou, Shuntai;
- Hill, Collin S;
- Woodburn, Blaide M D;
- Schinazi, Raymond F;
- Swanstrom, Ronald
Publication type:
Letter
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.
Published in:
2021
By:
- Zhou, Shuntai;
- Hill, Collin S;
- Sarkar, Sanjay;
- Tse, Longping V;
- Woodburn, Blaide M D;
- Schinazi, Raymond F;
- Sheahan, Timothy P;
- Baric, Ralph S;
- Heise, Mark T;
- Swanstrom, Ronald
Publication type:
journal article

Found: 6

N<sup>4</sup>-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses.

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.

Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission.

Reply to Troth et al.

β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.